Fayerweather Charles Has $275,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Fayerweather Charles held its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,143 shares of the medical equipment provider’s stock at the end of the second quarter. Fayerweather Charles’ holdings in Zimmer Biomet Holdings were worth $275,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Alpha Windward LLC raised its stake in shares of Zimmer Biomet Holdings by 1.1% in the first quarter. Alpha Windward LLC now owns 1,651 shares of the medical equipment provider’s stock valued at $202,000 after buying an additional 18 shares during the period. Sandy Spring Bank raised its stake in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares during the period. Parkside Financial Bank & Trust raised its stake in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares during the period. Cleararc Capital Inc. raised its stake in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares during the period. Finally, Enterprise Financial Services Corp raised its stake in shares of Zimmer Biomet Holdings by 1.0% in the first quarter. Enterprise Financial Services Corp now owns 2,637 shares of the medical equipment provider’s stock valued at $322,000 after buying an additional 27 shares during the period. 83.62% of the stock is owned by institutional investors.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded up 1.43% on Friday, hitting $111.70. The stock had a trading volume of 1,150,549 shares. The firm has a 50-day moving average price of $125.44 and a 200-day moving average price of $121.28. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The stock has a market capitalization of $22.59 billion, a P/E ratio of 31.81 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.02 EPS. Equities analysts expect that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.87%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

COPYRIGHT VIOLATION WARNING: “Fayerweather Charles Has $275,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/08/11/fayerweather-charles-maintains-stake-in-zimmer-biomet-holdings-inc-nysezbh-updated.html.

Several equities research analysts recently weighed in on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $140.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Jefferies Group LLC reaffirmed a “buy” rating and set a $148.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, June 30th. Citigroup Inc. lifted their target price on Zimmer Biomet Holdings from $108.00 to $130.00 and gave the company a “neutral” rating in a report on Friday, June 9th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $141.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $137.76.

In other news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit